# Oncology Therapeutic Radiopharmaceuticals: Nonclinical Studies and Labeling Recommendations Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/oncology-therapeutic-radiopharmaceuticals-nonclinical-studies-and-labeling-recommendations-guidance-for-industry/207c1c32-d577-4283-836d-ae7bb8e1ea92

> FDA guidance document: Oncology Therapeutic Radiopharmaceuticals: Nonclinical Studies and Labeling Recommendations Guidance for Industry. Issue date: August 02, 2019. Get complete insights and analysis.

---

## Details

- Title: Oncology Therapeutic Radiopharmaceuticals: Nonclinical Studies and Labeling Recommendations Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2019-08-02
- Last Changed: 2020-05-15
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-1772">FDA-2018-D-1772</a>

## Related Documents

- [Oncology Pharmaceuticals: Reproductive Toxicity Testing and Labeling Recommendations Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/oncology-pharmaceuticals-reproductive-toxicity-testing-and-labeling-recommendations-guidance-for-industry-guidance-for-industry/91713d82-572d-4f50-b440-cca500b50106)
- [Vulvovaginal Candidiasis:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/vulvovaginal-candidiasis-developing-drugs-for-treatment/3c14a50c-15d0-4ad3-94ec-76a32afa2bdb)
- [Osteoporosis:  Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/osteoporosis-nonclinical-evaluation-of-drugs-intended-for-treatment-guidance-for-industry-guidance-for-industry/8305ef9e-7edf-412b-bb46-28ef3a7f9493)